Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T C Chan

Showing results (361-370 of 407) with videos related to

Pageof 41
Sort By:
Journal of Gastroenterology and Hepatology|June 15, 2012
Digestive cancer management in Asia: position statements: a report on GI Oncology Summit in 2011Joseph J Y Sung, Enders K W Ng, Jaw-Town Lin, et al.
JCO Global Oncology|April 10, 2026
Distribution of Immune Cells in Tumor Microenvironment Correlates With Checkpoint Inhibitor Response in Nasopharyngeal Carcinoma: A Multiregional StudyBhumsuk Keam, Darren Wan-Teck Lim, Hsiang-Fong Kao, et al.
Cancer Cell|March 7, 2025
Fragmentomics profiling and quantification of plasma Epstein-Barr virus DNA enhance prediction of future nasopharyngeal carcinomaW K Jacky Lam, Guannan Kang, Charles M L Chan, et al.
Oral Oncology|January 25, 2018
Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: A report of 3328 patients (HKNPCSG 1301 study)K H Au, Roger K C Ngan, Alice W Y Ng, et al.
Cancer Chemotherapy and Pharmacology|June 20, 2006
Irofulven as first line therapy in recurrent or metastatic gastric cancer: a phase II multicenter study by the Cancer Therapeutics Research Group (CTRG)W Yeo, M Boyer, H C Chung, et al.
Cancer Research|June 11, 2009
CMTM3, located at the critical tumor suppressor locus 16q22.1, is silenced by CpG methylation in carcinomas and inhibits tumor cell growth through inducing apoptosisYu Wang, Jisheng Li, Yan Cui, et al.
Nature Communications|July 24, 2019
Methylation analysis of plasma DNA informs etiologies of Epstein-Barr virus-associated diseasesW K Jacky Lam, Peiyong Jiang, K C Allen Chan, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2018
Sequencing-based counting and size profiling of plasma Epstein-Barr virus DNA enhance population screening of nasopharyngeal carcinomaW K Jacky Lam, Peiyong Jiang, K C Allen Chan, et al.
AJNR. American Journal of Neuroradiology|March 19, 2020
Early Detection of Cancer: Evaluation of MR Imaging Grading Systems in Patients with Suspected Nasopharyngeal CarcinomaA D King, J K S Woo, Q-Y Ai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2016
What Is the Best Treatment of Locally Advanced Nasopharyngeal Carcinoma? An Individual Patient Data Network Meta-AnalysisLaureen Ribassin-Majed, Sophie Marguet, Anne W M Lee, et al.
Pageof 41

Showing results (361-370 of 407) with videos related to

Sort By:
Pageof 41
Journal of Gastroenterology and Hepatology|June 15, 2012
Digestive cancer management in Asia: position statements: a report on GI Oncology Summit in 2011Joseph J Y Sung, Enders K W Ng, Jaw-Town Lin, et al.
JCO Global Oncology|April 10, 2026
Distribution of Immune Cells in Tumor Microenvironment Correlates With Checkpoint Inhibitor Response in Nasopharyngeal Carcinoma: A Multiregional StudyBhumsuk Keam, Darren Wan-Teck Lim, Hsiang-Fong Kao, et al.
Cancer Cell|March 7, 2025
Fragmentomics profiling and quantification of plasma Epstein-Barr virus DNA enhance prediction of future nasopharyngeal carcinomaW K Jacky Lam, Guannan Kang, Charles M L Chan, et al.
Oral Oncology|January 25, 2018
Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: A report of 3328 patients (HKNPCSG 1301 study)K H Au, Roger K C Ngan, Alice W Y Ng, et al.
Cancer Chemotherapy and Pharmacology|June 20, 2006
Irofulven as first line therapy in recurrent or metastatic gastric cancer: a phase II multicenter study by the Cancer Therapeutics Research Group (CTRG)W Yeo, M Boyer, H C Chung, et al.
Cancer Research|June 11, 2009
CMTM3, located at the critical tumor suppressor locus 16q22.1, is silenced by CpG methylation in carcinomas and inhibits tumor cell growth through inducing apoptosisYu Wang, Jisheng Li, Yan Cui, et al.
Nature Communications|July 24, 2019
Methylation analysis of plasma DNA informs etiologies of Epstein-Barr virus-associated diseasesW K Jacky Lam, Peiyong Jiang, K C Allen Chan, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2018
Sequencing-based counting and size profiling of plasma Epstein-Barr virus DNA enhance population screening of nasopharyngeal carcinomaW K Jacky Lam, Peiyong Jiang, K C Allen Chan, et al.
AJNR. American Journal of Neuroradiology|March 19, 2020
Early Detection of Cancer: Evaluation of MR Imaging Grading Systems in Patients with Suspected Nasopharyngeal CarcinomaA D King, J K S Woo, Q-Y Ai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2016
What Is the Best Treatment of Locally Advanced Nasopharyngeal Carcinoma? An Individual Patient Data Network Meta-AnalysisLaureen Ribassin-Majed, Sophie Marguet, Anne W M Lee, et al.
Pageof 41